Milestone Scientific, Inc. (MLSS) News

Milestone Scientific, Inc. (MLSS): $0.75

0.01 (-1.52%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Filter MLSS News Items

MLSS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

MLSS News Highlights

  • For MLSS, its 30 day story count is now at 5.
  • Over the past 5 days, the trend for MLSS's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
  • The most mentioned tickers in articles about MLSS are AMP, LI and DEC.

Latest MLSS News From Around the Web

Below are the latest news stories about MILESTONE SCIENTIFIC INC that investors may wish to consider to help them evaluate MLSS as an investment opportunity.

Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common Stock

ROSELAND, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the closing of its previously announced underwritten public offering of 4,765,000 shares of its common stock at a public offering price of $0.63 per share (the “Offering”). Gross proceeds before deducting underwriting discounts, commissions and other Offering expenses were approximately

Yahoo | December 13, 2023

Milestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common Stock

ROSELAND, N.J., Dec. 10, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the pricing of an underwritten public offering of 4,765,000 shares of its common stock at a price of $0.63 per share (the “Offering”). Gross proceeds before underwriting discounts and commissions and estimated Offering expenses are expected to be approximately $3.0 million. The Offering

Yahoo | December 11, 2023

Milestone Scientific announces proposed public offering of common stock

More on Milestone Scientific

Milestone Scientific Inc. Announces Proposed Public Offering of Common Stock

ROSELAND, N.J., Dec. 08, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced an underwritten public offering of shares of its common stock (the “Offering”). The Company also expects to grant to the underwriters a 45-day option to purchase up to an additional 15% of the shares of common stock offered in the Offering on the same terms and con

Yahoo | December 8, 2023

Milestone Scientific Commences Sales of CompuFlo®  Disposables for Use in Neurostimulation Spinal Cord Implantation Procedures

Adoption of the technology at UTMB Health Clear Lake Campus Hospital follows successful evaluation process in these procedures—reporting 100% success CompuFlo helps minimize intraoperative cerebral fluid leakageand trauma to underlying nerve roots ROSELAND, N.J., Dec. 08, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today reported it has commenced commercial sales of Com

Yahoo | December 8, 2023

Milestone Announces Agreement with Bioline Supply to Distribute the CompuFlo® Epidural System and Related Disposables Across Spain

ROSELAND, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced it has entered into an agreement with Bioline Supply to distribute the CompuFlo® Epidural System and related disposables in Spain. Bioline is a premier distributor of medical devices and equipment, supporting many hospitals and pain clinics across Spain. In connection with the agreement

Yahoo | November 28, 2023

Milestone Scientific Achieves Revenue of $2.1 Million and Provides Business Update for the Third Quarter of 2023

Reports 45% increase in domestic sales for the third quarter of 2023;new online store providing greater interaction with dentists and improved margins Gross profit margin increases to 73% for the third quarter of 2023, compared to 66% for the same period last year Medical division reports expansion of sales in a prominent hospital system, and pain management clinics Reports progress advancing reimbursement strategy for the CompuFlo® Epidural System ROSELAND, N.J., Nov. 15, 2023 (GLOBE NEWSWIRE)

Yahoo | November 15, 2023

Milestone Scientific Schedules Third Quarter 2023 Financial Results and Business Update Conference Call

ROSELAND, N.J., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Wednesday, November 15, 2023, to discuss the company’s financial results for the third quarter ended September 30, 2023, as well as the company’s corporate progress and other developments. The conference call will be availa

Yahoo | November 10, 2023

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Island Ambulatory Surgery Center in Brooklyn, New York

Represents first sales by the Company into an ambulatory surgery center Follows successful evaluation by Island Ambulatory Surgery Center’s founder and medical director, Dr. Leon Reyfman, reporting 100% success ROSELAND, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables into Island Am

Yahoo | November 9, 2023

Milestone Scientific Appoints Pain Management Industry Veteran Dr. Didier Demesmin to its Board of Directors

ROSELAND, N.J., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Dr. Didier Demesmin, MD, MBA, to the Board of Directors. Dr. Demesmin is an interventional pain medicine physician who is double board-certified in both anesthesiology and pain medicine. He is the founder of University Pain and Spine center, a well-respected interve

Yahoo | September 12, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!